Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
18.22
+0.78 (4.47%)
At close: Oct 15, 2026, 4:00 PM EDT
18.22
0.00 (0.00%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Viatris Market Cap
Viatris has a market cap or net worth of $20.93 billion as of October 15, 2026. It is the 1,182nd most valuable company in the world and the 476th biggest in the United States. Its market cap has increased by 80.76% in one year.
Market Cap
20.93B
Enterprise Value
33.04B
1-Year Change
80.76%
Global Rank
Country Rank
#476 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Viatris's market cap has increased from $4.38B to $20.93B, an increase of 377.69%. That is a compound annual growth rate of 5.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 20.93B | 45.94% |
| Dec 31, 2025 | 14.34B | -3.50% |
| Dec 31, 2024 | 14.86B | 14.38% |
| Dec 29, 2023 | 12.99B | -3.74% |
| Dec 30, 2022 | 13.50B | -17.51% |
| Dec 31, 2021 | 16.36B | 61.24% |
| Dec 31, 2020 | 10.15B | -2.18% |
| Dec 31, 2019 | 10.37B | -26.57% |
| Dec 31, 2018 | 14.13B | -37.75% |
| Dec 29, 2017 | 22.70B | 11.18% |
| Dec 30, 2016 | 20.41B | -23.22% |
| Dec 31, 2015 | 26.59B | 26.03% |
| Dec 31, 2014 | 21.10B | 26.97% |
| Dec 31, 2013 | 16.62B | 48.53% |
| Dec 31, 2012 | 11.19B | 22.22% |
| Dec 30, 2011 | 9.15B | 39.85% |
| Dec 31, 2010 | 6.54B | 16.21% |
| Dec 31, 2009 | 5.63B | 86.89% |
| Dec 31, 2008 | 3.01B | -13.89% |
| Dec 31, 2007 | 3.50B | -17.30% |
| Dec 29, 2006 | 4.23B | -1.54% |
| Dec 30, 2005 | 4.30B | -9.67% |
| Dec 31, 2004 | 4.76B | -29.94% |
| Dec 31, 2003 | 6.79B | 58.86% |
| Dec 31, 2002 | 4.27B | -9.23% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 59.82B |
| Teva Pharmaceutical Industries | 48.02B |
| Haleon | 41.31B |
| Zoetis | 31.03B |
| United Therapeutics | 23.40B |
| Neurocrine Biosciences | 13.83B |
| Elanco Animal Health | 11.19B |
| Dr. Reddy's Laboratories | 10.81B |